sapropterin has been researched along with Central Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anstey, NM; DeRisi, JL; Florence, SM; Granger, DL; Hyland, K; Langelier, C; Lopansri, BK; Mukemba, JP; Mwaikambo, ED; Nakielny, S; Rubach, MP; Simmons, RA; Weinberg, JB; Yeo, TW | 1 |
| Nomura, T; Ohtsuki, M; Shiraishi, H; Sumi-Ichinose, C | 1 |
1 review(s) available for sapropterin and Central Nervous System Diseases
| Article | Year |
|---|---|
[Perspectives on tetrahydrobiopterin research].
Topics: Animals; Arteriosclerosis; Biopterins; Central Nervous System Diseases; GTP Cyclohydrolase; Humans; Mice; Mice, Knockout; Phosphorus-Oxygen Lyases | 2001 |
1 other study(ies) available for sapropterin and Central Nervous System Diseases
| Article | Year |
|---|---|
Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.
Topics: Biopterins; Central Nervous System Diseases; Child; Child, Preschool; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Malaria, Cerebral; Male; Neopterin; Neurotransmitter Agents; Prospective Studies; Pterins; Reference Values; Tanzania; Tyrosine | 2021 |